24 May 2013
Keywords: sanofi, denies, making, 3b, bid, imclone, leading
Article | 23 October 2006
Leading French drugmaker Sanofi-Aventis has denied it has any interest in acquiring US biotechnology firm ImClone. However, US media sources ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.